Abstract : In this review, we summarize the molecular mechanisms of chemical inhibitors and small interference RNAs (siRNAs) specifically targeted against signaling factors involving in heat-induced signal transduction pathways for anti-apoptosis/cellular proliferation and DNA repair. Since there are still few reports of the chemical inhibitors and siRNAs with respect to sensitization to heat, the effective chemical inhibitors and siRNAs which block the signal transduction pathways are required from an aspect of fundamental research. We expect the attractive sensitizers described here to contribute to high curative efficiency in hyperthermic cancer therapy.
Introduction
Hyperthermia has been developed as one of the efficacious cancer therapies 1) 2). To develop more efficient regimens for treating various malignant tumors, useful agents that sensitize cancer cells to hyperthermia are still strongly required. Inhibitors which interfere with anti-apoptosis/cellular proliferation signal transductions are now being developed to enhance heat-induced cell killing.
Recent molecular biological studies have addressed the heat-induced signal transduction pathways for apoptosis. Apoptosis is a beneficial physiological response resulting in cell death without inflammation. Heat-induced apoptosis has been reported to be induced through p53-centered 3) and/or c-Jun N-terminal kinase (JNK)-centered signal transduction 4) 5). On the other hand, heat activates signal transduction pathways not only for apoptosis but also for anti-apoptosis/cellular proliferation. Several signaling factors, such as Akt, p38, extracellular signal-regulated kinase (ERK) and heat shock protein (HSP), play important roles in anti-apoptosis/cellular proliferation pathway. Such signaling factor-related pathways are disadvantageous to hyperthermic cancer therapy. Therefore, targeted inhibition of such signaling factors is useful for the development of potent hyperthermic cancer therapy .
It is worth notice that Trastuzumab and ZD1839 (also called Herceptin and Iressa, respectively) that inhibit anti-apoptosis/cellular proliferation pathways have caused good outcomes in breast and lung RNA interference (RNAi) has become a useful tool for selective suppression of targeted gene expression to clarify the molecular mechanisms of the expression of various genes. Based on its mechanism of action, RNAi has been applied for the enhancement of radiosensitivity or chemosensitivity of cells 8) 9). Application of RNAi was first noted in Caenorhabditis elegans as a novel mechanism of post-transcriptional gene silencing, and thereafter it was confirmed in many eukaryotes 10) 11). mRNA of a targeted gene is cleaved by an RNA-induced silencing complex (RISC), a complex of sequence-specific double-stranded RNA molecules called siRNA and a nuclease. Each siRNA targeted against ataxia telangiectasia-mutated protein kinase (ATM), ATM-and Rad3-related protein kinase (ATR) or DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which contributes to DNA repair machinery, suppresses the gene expression of their respective genes, leading to enhanced radiosensitivity or chemosensitivity. Interestingly, this strategy using siRNAs can be applied for hyperthermic cancer therapy as well as radiation cancer therapy, because we recently obtained data showing that siRNA targeted for a DNA repair protein enhances heat sensitivity. In this review, we mentioned possible effectiveness of siRNA as a sensitizer in hyperthermic cancer therapy.
Signal transduction
for apoptosis after heating 1-1. p53 pathway
In cancer therapy, the biological implications of radiation-induced apoptosis have recently been focused. We have shown that mutant (mp53) and deletion-type cancer cells of tumor suppressor gene p53 were more resistant to radiation than the wild-type p53 (wtp53) cancer cells using human cultured squamous cell carcinoma cell lines (SAS cells bearing wtp53) and p53-null human lung cancer cell lines (H 1299 cells) which were transfected with mp53 or wtp53gene 12) 13). DNA array analysis has shown that the expression of apoptosis-inductive genes, such as DNA fragmentation factor-40 (DFF40), caspase-3, -8 , -9, -10 and caspase and RIP adapter with death domain (CRADD), was increased by X-ray irradiation in SAS/neo, but not in SAS/mp53. The p53-dependent radiation sensitivity of SAS cells was considered to be induced by the expression of these apoptosis-related genes 14). The p53-dependent radiation sensitivity was also shown in in vivo experiments using nude mice transplanted with SAS/mp53 or SAS/neo cells 15). In clinical investigations in human cervical carcinomas, p53-dependent apoptosis-related factors such as bcl-2 associated x (Bax) and B-cell lymphoma/leukemia-2 (Bcl-2) have been reported to be good candidates for predictive indicators for radio-cancer therapy 16-18) ; that is, the survival rate of cancer patients with positive response of Bax and negative response of Bcl-2 is higher than that of cancer patients with negative response of Bax and positive response of Bcl-2.
In contrast, our understanding of the physiological functions of heat-induced p53-dependent signal transduction in human cancer cells is still vague as compared with that of radiation-induced p53-dependent signal transduction.
We have reported the p53-dependent heat sensitivity of human cancer cell lines. SAS/mp53 cells and mp53-transfected human glioblastoma cells (A-172/mp53 cells) had a lower survival rate or incidence of apoptosis via Bax than neo control cells 3) 19). DNA array analysis has shown that an anti-apoptosis-related gene, IL-12, expresses more intensely in SAS/mp53 cells than SAS/neo cells 20). These results strongly suggest that the heat sensitivity of cancer cells depends on tumor-transplanted mice than in mp53 tumor-transplanted mice. In accordance with this, the incidence of apoptosis via caspase-3 was higher in wtp53 tumor than in mp53 tumor. We have reported p53-dependent hyperthermic enhancement of tumor growth inhibition in X-ray or carbon-ion beam-irradiated mice as well 22).
Heat-induced p53-dependent signal transduction pathways are shown in Fig. 1 . ATM phosphorylated by heat activates p53 23) 24) and the p53 induces Bax-mediated apoptosis via caspase-3 3), like p53 activated by genotoxic stress 25) 26). This p53-dependent signal transduction is one of the pathways for heat-induced apoptosis. In another p53-mediated pathway, FS-7-associated-surface antigen (Fas), a downstream factor of p53, also activates the caspase family 27) 28). The signal transduction pathway via Fas is also likely to contribute to heat-induced p53-dependent apoptosis in human lymphoid cells 29) and human colorectal carcinoma cells 30). The survival rate of the colorectal carcinoma cells was well correlated with apoptosis induction 39). 
2-2. Inhibitors of Akt pathway 2-2-1. PI3-K inhibitors
Wortmannin inhibits the activity of DNA-PK at lower doses and ATM at higher doses ( Fig. 1 ). As DNA-PK and ATM contribute to the DNA repair machinery, it has been reported that wortmannin enhances the radiosensitivity of cancer cells 58) 59). Another report showed that wortmannin enhances the radiosensitivity of ataxia telangiectasia cells, but it does not enhance the radiosensitivity of DNA-PK-deficient cells 60). Therefore, it is possible that wortmannin sensitizes cells to radiation through inhibition of the DNA-PK-mediated DNA repair. Enhancement of apoptosis by wortmannin has also been reported in a human breast cancer cell line 61). In contrast to wortmannin, 2-(4-morpholinyl) -8-phenyl-4H-l-benzopyran-4-one (LY294002) sensitizes not only radiosensitivity but also heat-sensitivity (our unpublished data). The mechanism of the inhibition of heat-induced PI3-K activation seems to be different between wortmannin and LY294002. LY294002 might sensitize cells to heat via the inhibition of unknown heat-induced anti-apoptotic pathway. Radio-sensitization with LY294002 has been reported by in vitro 58) and in vivo 62) experiments but heat sensitization with LY294002 has not been reported.
2-2-2. PDK1 inhibitor 7-hydroxystaurosporine (UCN-01) has been used as a PDK1-inhibitory drug in clinical trials.
UCN-01 induces Akt inactivation by inhibiting PDK1 directly (Fig. 1) , resulting in the suppression of the survival signals and the induction of apoptosis 63). Staurosporine has also been reported to suppress PDK1 directly 63).
2-2-3. NF-KB inhibitor
Dicoumarol, a coumarin derivative, was reported to potentiate TNF-induced apoptosis in HeLa cells, probably by blocking the anti-apoptotic effect of NF-KB and is currently used clinically 64). Since NF-KB is a target of Akt, dicoumarol is a potential hyperthermic cancer therapeutic inhibitor of NF-KB.
2-3. HSP inhibitors
HSP27, 72 and 90 play inhibitory roles in varied signal transduction pathways for apoptosis (Fig. 1) .
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One of these roles is to interfere with the formation of the apoptosome, which consists of apoptosis protease-activating factor-1 (Apaf-1), caspase-9 and cytochrome c. 
